This indefinite delivery contract was awarded by the Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense to Meso Scale Diagnostics LLC, doing business as Meso Scale Discovery. Meso Scale Diagnostics is a for-profit limited liability company that provides assay development services, laboratory testing equipment, immunoassays, multiplex assay kits, and related products to support biomedical research and testing efforts for various federal agencies. The...
The federal agency Department of the Army Medical Command awarded a single-award Indefinite Delivery Contract (IDC) to Euroimmun US Incorporated, a subsidiary of PerkinElmer, for the provision of IMMUNODIAGNOSTIC SYSTEMS (IDS) REAGENTS AND SUPPLIES. The contract has a potential value of $2,400,000.00 and a period of performance from January 4, 2024 through January 3, 2029. Euroimmun, the prime contractor, will deliver medical testing equipment and SARS-CoV-2 antibody test kits to support the...
The Department of the Army Medical Command awarded an Indefinite Delivery Contract (IDC) to EMD Millipore Corp, a foreign-owned manufacturer, for the procurement of multiplex assay kits. The $17,248.00 single-award contract has a period of performance through September 30, 2022 and does not utilize any set-asides. Under this IDC, a $8,624.00 firm fixed-price delivery order was issued for the initial purchase of the multiplex assay kits. EMD Millipore Corp is a provider of a wide range of...
Microgenics Corporation, a division of Thermo Electron Corporation's Clinical Diagnostics business, has been awarded multiple firm fixed price delivery orders under an Indefinite Delivery Contract (IDC) by the Department of the Navy Bureau of Medicine and Surgery. The delivery orders, valued from $4,013 to $34,913.10, are for the provision of DRI-ECSTASY PLUS MDMA/MDA and other reagent kits to support the Bureau's drug testing and identification programs at Navy and Marine Corps medical...
Abbott Laboratories Inc., through its Abbott Diagnostics Division, has been awarded an indefinite delivery contract by the Defense Health Agency to provide immunochemistry reagents. The contract has a potential value of $3.78 million and a period of performance through September 2023. Task orders issued to date include a $1.4 million order for the Defense Health Agency and orders valued at $1.89 million and $1.2 million for the Department of the Army Medical Command. Performance will take...
This is a federal Indefinite Delivery Contract (IDC) awarded by the U.S. Department of Veterans Affairs' Veterans Integrated Service Network 17 (VISN 17) to Sysmex America, Inc., a U.S. subsidiary of the Japanese medical equipment manufacturer Sysmex Corporation. The contract, with a ceiling value of $330,000, is for the provision of Erythrocyte Sedimentation Rate (ESR) testing services on a cost-per-test basis over a 5-year ordering period from September 2024 to September 2029. The contract...
This Blanket Purchase Agreement (BPA) contract, awarded by the U.S. Army Medical Command (MEDCOM) to Siemens Healthcare Diagnostics Inc., provides reagents, test kits, and consumables for the Siemens Dimension EXL 200 Integrated Chemistry System and Siemens Immulite 2000 Immunoassay System. The contract has a ceiling value of $6,743,294.25 and a period of performance through April 17, 2027. The awarded task orders, valued at $2,752.14, $4,632.00, $4,632.00, $13,845.95, $11,738.40, and $8,701.11,...
Siemens Healthcare Diagnostics Inc., a subsidiary of Siemens Aktiengesellschaft, has been awarded multiple firm fixed price delivery orders by various U.S. federal agencies to provide 6-AM reagent kits and related laboratory diagnostic products and services. The Department of the Navy Bureau of Medicine and Surgery, Department of the Air Force Air Education and Training Command, Defense Health Agency, and Department of the Army Medical Command have all issued awards to Siemens Healthcare...
This federal Indefinite Delivery Contract (IDC) award, with a ceiling value of $4,099,060.31, was made by the Defense Health Agency (DHA) to Abbott Laboratories Inc. (Abbott), a global healthcare company, for the provision of IMMUNOCHEMISTRY REAGENTS. The contract has an ultimate completion date of September 30, 2025 and is a single-award vehicle, with no set-aside designation. Two delivery orders have been issued under this IDC. The first, valued at $1,778,600.15, has a completion date of...
The U.S. Air Education and Training Command has awarded a Blanket Purchase Agreement (BPA) to Abbott Laboratories Inc.'s Abbott Diagnostics Division to provide reagents, consumables, and related services necessary to operate the Alinity S blood and plasma analyzer located at the Armed Services Blood Bank Center-San Antonio (ASBBC-SA) in JBSA Lackland, Texas. This single-award BPA, valued at up to $7,000,000 over its period of performance from October 1, 2024 to April 30, 2026, will streamline...